MCAP — MedCap AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK5.77bn
- SEK5.77bn
- SEK1.81bn
- 93
- 20
- 28
- 41
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 24.45 | ||
| PEG Ratio (f) | 2.92 | ||
| EPS Growth (f) | 9.12% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.5 | ||
| Price to Tang. Book | 9.39 | ||
| Price to Free Cashflow | 19.65 | ||
| Price to Sales | 3.19 | ||
| EV to EBITDA | 14.87 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.4% | ||
| Return on Equity | 18% | ||
| Operating Margin | 15.07% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 817.4 | 916.3 | 1,111.3 | 1,587.4 | 1,806.7 | 2,082.5 | 2,298.5 | 19% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +6.43 | +49.27 | +23.75 | +48.33 | +20.74 | +0.01 | +30.52 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Directors
- Peter Von Ehrenheim NEC (66)
- Anders Dahlberg CEO (42)
- Kristina Ekblad CFO (47)
- Lars Angman OTH (49)
- Johan Folkunger OTH (53)
- Anders Hansen IND (47)
- Anders Lundmark IND (63)
- Nina Rawal IND (42)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 23rd, 2001
- Public Since
- July 4th, 2006
- No. of Employees
- 556
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 14,972,853
- Address
- Engelbrektsgatan 9-1, STOCKHOLM, 114 32
- Web
- https://www.medcap.se/
- Phone
- +46 8347110
- Contact
- Anders Dahlberg
- Auditors
- KPMG AB
Upcoming Events for MCAP
MedCap AB (publ) Annual Shareholders Meeting
Q2 2025 MedCap AB (publ) Earnings Release
Similar to MCAP
ABG Sundal Collier Holding ASA
OMX Nordic Exchange Stockholm
Adventure Box Technology AB (publ)
OMX Nordic Exchange Stockholm
Alpcot Holding AB (publ)
OMX Nordic Exchange Stockholm
Aquila Holdings ASA
OMX Nordic Exchange Stockholm
Athanase Innovation AB
OMX Nordic Exchange Stockholm
FAQ
What is the MedCap AB (publ) share price?
As of Today at 21:57 UTC, shares in MedCap AB (publ) are trading at SEK385.50. This share price information is delayed by 15 minutes.
How has the MedCap AB (publ) share price performed this year?
Shares in MedCap AB (publ) last closed at SEK385.50 and the price had moved by -4.22% over the past 365 days. In terms of relative price strength the MedCap AB (publ) share price has underperformed the FTSE Global All Cap Index by -5.91% over the past year.
What are the analyst and broker recommendations for MedCap AB (publ)?
The overall consensus recommendation for MedCap AB (publ) is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the MedCap AB (publ) dividend yield?
MedCap AB (publ) does not currently pay a dividend.
Does MedCap AB (publ) pay a dividend?
MedCap AB (publ) does not currently pay a dividend.
When does MedCap AB (publ) next pay dividends?
MedCap AB (publ) does not currently pay a dividend.
How do I buy MedCap AB (publ) shares?
To buy shares in MedCap AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of MedCap AB (publ)?
As of the previous close price of SEK385.50, shares in MedCap AB (publ) had a market capitalisation of SEK5.77bn.
Where are MedCap AB (publ) shares listed?
Here are the trading details for MedCap AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: MCAP
What kind of share is MedCap AB (publ)?
Based on an overall assessment of its quality, value and momentum MedCap AB (publ) is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a MedCap AB (publ) share price forecast for 2025?
The analyst consensus target price for shares in MedCap AB (publ) is SEK547.50. That is 42.02% above the last closing price of SEK385.50.
Analysts covering MedCap AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of SEK14.45 for the next financial year.
Find out moreWhat is the trend in the MedCap AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MedCap AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -26.5%.
As of the last closing price of SEK385.50, shares in MedCap AB (publ) were trading -21.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the MedCap AB (publ) PE Ratio?
The MedCap AB (publ) PE ratio based on its reported earnings over the past 12 months is 24.45. The shares last closed at SEK385.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of MedCap AB (publ)?
MedCap AB (publ)'s management team is headed by:
- Peter Von Ehrenheim - NEC
- Anders Dahlberg - CEO
- Kristina Ekblad - CFO
- Lars Angman - OTH
- Johan Folkunger - OTH
- Anders Hansen - IND
- Anders Lundmark - IND
- Nina Rawal - IND